Viking Global Management

Viking Global Management is a premier global investment firm that plays a critical role in the life sciences and healthcare ecosystem as a major source of capital. Founded in 1999 by Tiger Management alumnus O. Andreas Halvorsen, the firm manages significant assets across public and private equity markets. Viking is particularly noted for its deep-dive fundamental research into biotechnology, often leading large funding rounds for innovative drug discovery platforms and maintaining substantial stakes in large-cap pharmaceutical entities. The firm's healthcare portfolio spans diverse therapeutic areas, including oncology, rare diseases, and gene therapy, making it a key influencer in biotech valuations and development trends.